Flashpoint Therapeutics

Redwood City, United States

Flashpoint Therapeutics introduces a new way to building cancer immunotherapies.

$10.0M raised

Oct 2023

Seed

Biotechnology Medical Therapeutics

Top Investors

CS Venture Opportunities Fund Beta Lab

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Flashpoint Therapeutics

How much funding has Flashpoint Therapeutics raised?

Flashpoint Therapeutics has raised $10.0M in total funding. The most recent round was Seed. The last funding was announced in October 2023.

Who are Flashpoint Therapeutics's investors?

Flashpoint Therapeutics's investors include CS Venture Opportunities Fund, Beta Lab.

Where is Flashpoint Therapeutics headquartered?

Flashpoint Therapeutics is headquartered in Redwood City, United States.

What does Flashpoint Therapeutics do?

Flashpoint Therapeutics introduces a new way to building cancer immunotherapies.

What stage is Flashpoint Therapeutics at?

Flashpoint Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 25, 2023.

MLA

"Flashpoint Therapeutics — Funding & Investors." VCBacked, October 25, 2023, https://www.vcbacked.co/company/flashpoint-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2023). Flashpoint Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/flashpoint-therapeutics

Wikipedia (cite web)

{{cite web |title=Flashpoint Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/flashpoint-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 25, 2023.